Physician profile
Michael Varvara
NPI 1578938874
$6,681.47
in general payments reported to CMS, 2019-2025
14 companies · $1,315 in 2025
The $1,315 reported for 2025 was more than what 85% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $895 · 2022: $797 · 2023: $1,764 · 2024: $1,911 · 2025: $1,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,989.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,969.31 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Linq II |
| Abbott Laboratories | $2,355.77 | 2021-2025 | Aveir, Gallant, Ensite Precision |
| Boston Scientific Corporation | $700.81 | 2021-2025 | Watchman Flx, Latitude Communicator Power Supply, Farapulse |
| Edwards Lifesciences Corporation | $195.72 | 2024 | Hemosphere |
| Cardiva Medical, INC. | $186.48 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade 6/7f Vcs |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.16 | 2021-2022 | |
| Biosense Webster, INC. | $53.74 | 2023 | Carto 3 |
| Atricure, INC. | $42.38 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $24.21 | 2025 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $23.06 | 2025 | |
| Sanofi-Aventis U.S. LLC | $22.31 | 2022 | |
| Merck Sharp & Dohme LLC | $18.79 | 2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $16.82 | 2022 | |
| Elutia, INC. | $2.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Varvara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.